GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Float Percentage Of Total Shares Outstanding

Toleranzia AB (OSTO:TOL) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 23, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Toleranzia AB's float shares is 0.00 Mil. Toleranzia AB's total shares outstanding is 197.07 Mil. Toleranzia AB's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Toleranzia AB's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Toleranzia AB's Institutional Ownership is 0.01%.

Toleranzia AB Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Toleranzia AB's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/197.07
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Toleranzia AB (OSTO:TOL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XSAT:DANCAN OSTO:NANEXA OSTO:MOB OSTO:ERMA OSTO:ALZCUR XSAT:PMED OSTO:NEWBRY XSAT:ODI OSTO:GABA XSAT:ACUC XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Website
https://www.toleranzia.com
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.